Tech Company Financing Transactions
iXCells Biotechnologies Funding Round
iXCells Biotechnologies closed a funding round on 9/30/2022. Investors included Great Point Partners.
Transaction Overview
Company Name
Announced On
9/30/2022
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
7270 Trade St. 102
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
iXCells Biotechnologies is a cell biology and cell technology company dedicated to providing innovative pre-clinical drug discovery solutions with the focus on disease relevant cellular models enabling technologies and services to the academic, biotech and pharma communities to accelerate the pace of drug discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Nianwei Lin
Browse more venture capital transactions:
Prev: 9/30/2022: Pulp Culture venture capital transaction
Next: 9/30/2022: Uniswap venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs